FDA Adverse Event Other Summary report: N

RBC (RBX) SET, SPECTRA

MDR report key: 1890866 · Received October 28, 2010

Report

Report Number
1722028-2010-00060
Event Type
Other
Date Received
October 28, 2010
Date of Event
May 26, 2010
Report Date
October 29, 2010
Manufacturer
CARIDIANBCT
Product Code
LKN
PMA / PMN Number
K9000105
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE PT HAD SICKLE CELL ANEMIA AND HIS TOTAL BLOOD VOLUME WAS RECORDED AS 5374 ML. HIS PRE-PROCEDURE HEMATOCRIT WAS 37%. THE OPERATOR DID NOT FOLLOW THE PROCEDURE FROM THE OPERATOR'S MANUAL. THEY FOLLOWED A CUSTOM PROTOCOL, DEVELOPED BY ONE OF THEIR PHYSICIANS. THIS PROTOCOL INVOLVED INITIATING AN RBC DEPLETION AND THEN CHANGING TO AN RBC EXCHANGE. THE FLUID BALANCE WAS SET AT 100%. THE CUSTOMER STATED THAT THEY DID NOT EXPERIENCE ANY ALARMS OR ISSUES DURING THE PROCEDURE. AFTER THE PROCEDURE WAS COMPLETED, THE MACHINE INDICATED THAT ABOUT 3500 ML SHOULD HAVE BEEN REMOVED FROM THE PT. THE COLLECT BAG APPEARED TO CONTAIN ONLY ABOUT 700-800 ML. THE PT'S HEMATOCRIT POST-PROCEDURE WAS 41.5%, HIGHER THAN THE 33% PREDICTED BY THE MACHINE. A PHYSICIAN WAS NOTIFIED. THE PHYSICIAN EVALUATED THE PT AND DETERMINED THAT THE PT WAS FINE. THE PT WAS ALLOWED TO LEAVE WITHOUT ANY MEDICAL INTERVENTION AND REPORTEDLY FELT WELL. THE "MACHINE CHECKOUT" DID NOT REVEAL ANY ISSUES WITH THE COBE SPECTRA EQUIPMENT. THE COBE SPECTRA DISPOSABLE WAS RECEIVED AND VISUALLY INSPECTED AND NONE WERE OBSERVED. ALSO, NO SIGNIFICANT "KINKS" WERE OBSERVED ON THE TUBING. THE SMALL INDENTATION THE CUSTOMER DESCRIBED AS A "KINK" WAS LOCATED ON THE RBC AND PLASMA LINES OF THE LOOP ASSEMBLY. THE INDENTATIONS OBSERVED AFTER THE KIT WAS RETURNED WERE NOT SEVERE ENOUGH TO FULLY OCCLUDE THE TUBING SET; HOWEVER, THESE INDENTATIONS COULD BE EVIDENCE THAT THE TUBING WAS PINCHED ENOUGH DURING THE PROCEDURE TO AFFECT THE FLUID PATHWAY. IF VOLUME IN COLLECT BAG WAS ACCURATE, HYPERVOLEMIA COULD RESULT. DOCTOR WAS AWARE OF THIS CONDITION.

Description of Event or Problem · 1

THIS REPORT IS BEING FILED AS A RESULT OF CHANGES TO OUR MDR EVAL PROCESS THAT WERE PROMPTED BY AN FDA INSPECTION. THE FOLLOWING INCIDENT DESCRIPTION WAS PROVIDED TO CARIDIANBCT QUALITY ASSURANCE. AFTER A RED BLOOD CELL EXCHANGE (RBCX) PROCEDURE USING A COBE SPECTRA MACHINE AND A COBE SPECTRA DISPOSABLE, THE CUSTOMER REPORTED A DISCREPANCY BETWEEN THE RED CELL VOLUME COLLECTED AND THE VOLUME DISPLAYED BY THE COBE SPECTRA MACHINE. THE PT DID NOT EXPERIENCE ANY ADVERSE HEALTH EFFECTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RBC (RBX) SET, SPECTRA SEPARATOR, AUTOMATED, BLOOD CELL AND PL LKN CARIDIANBCT 950000000 02S15270

Patients

Seq Age Sex Outcome Treatment
1 UNK